FDA Brief

Company record

ENDO USA, Inc.

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about ENDO USA, Inc..

Recalls

ReportedClassFirmProduct and reason
May 20 Class II ENDO USA, Inc.
Drug
Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
Crystallization; identified as Buprenorphine free base